Skip to content
  • Happy Health
  • Happy Mindset
  • Animal Wonders
  • About Us
    • Team
  • Subscribe
Menu
  • Happy Health
  • Happy Mindset
  • Animal Wonders
  • About Us
    • Team
  • Subscribe
Happy News

For The First Time In History Medicare Is Covering Weight Loss Drugs And The Price Is $50 A Month

Starting July 1, 2026 eligible Medicare enrollees will be able to access GLP-1 weight loss medications including Wegovy, Zepbound, and the newer drug Foundayo for a flat $50 monthly copay, in a historic first for the program, which has never before covered anti-obesity medications despite covering many of the serious health conditions that obesity contributes to. The initiative, called the Medicare GLP-1 Bridge, is a pilot program run by the Centers for Medicare and Medicaid Services that will operate through December 31, 2027, offering a consistent $50 monthly copay that does not increase with dosage. Without the program, these medications carry retail prices that often exceed $1,000 per month, and a recent survey found that more than half of GLP-1 users described them as difficult to afford even when they had some coverage. CMS Administrator Dr. Mehmet Oz said the Bridge changes that by making medications that are a major medical advancement accessible to seniors who were previously priced out.

To qualify, Medicare enrollees must be enrolled in a Part D prescription drug plan and meet clinical criteria: a BMI of 30 or higher, or a BMI of 27 or higher combined with a qualifying condition such as heart disease, prediabetes, high blood pressure, chronic kidney disease, or sleep apnea. Both injectable and pill forms of the eligible drugs are covered, which is significant because many older adults find injectables difficult to use due to arthritis or other physical limitations. There are trade-offs worth knowing: the $50 copay does not count toward the Part D deductible or the $2,100 annual out-of-pocket cap, and low-income subsidy benefits cannot be applied to Bridge prescriptions. Beneficiaries who want to explore eligibility should speak with their doctor before July 1, since prior authorization will be required.

Source: https://abcnews.com/GMA/Wellness/medicare-enrollees-glp-1-drugs-50-starting-july/story?id=132738089

PrevPreviousSwedish Scientists Just Grew The Cells Type 1 Diabetes Destroys From Scratch

Recent Articles

Happy News

For The First Time In History Medicare Is Covering Weight Loss Drugs And The Price Is $50 A Month

May 14, 2026

Starting July 1, 2026 eligible Medicare enrollees will be able to access GLP-1 weight loss medications including Wegovy, Zepbound, and the newer drug Foundayo for a flat $50 monthly copay, in a historic first for the program, which has never before covered anti-obesity medications despite covering many of the serious

Read More
Happy News

Swedish Scientists Just Grew The Cells Type 1 Diabetes Destroys From Scratch

May 13, 2026

Scientists at Karolinska Institutet and KTH Royal Institute of Technology in Sweden have developed a more reliable method for growing insulin-producing cells from human stem cells, and the results published in Stem Cell Reports represent one of the most encouraging steps yet toward a potential treatment for type 1 diabetes.

Read More
Happy News

New Research Reveals The Personality Trait That Predicts Whether You Will Seek Out A Cat When Stressed

May 12, 2026

A study published in the journal Anthrozoös, conducted by researchers at Washington State University and KU Leuven in Belgium, has identified the personality trait most likely to predict whether someone will seek out a cat for stress relief rather than a dog, and the answer has a name: emotionality. Researchers

Read More
« Previous Next »
  • Privacy Notice
  • Accessibility Notice
  • Do Not Sell or Share My Personal Information
  • Unsubscribe
  • Terms and Conditions
  • Privacy Policy
  • Privacy Notice
  • Accessibility Notice
  • Do Not Sell or Share My Personal Information
  • Unsubscribe
  • Terms and Conditions
  • Privacy Policy
Copyright © 2026 HappyNews.